Zeta Navigation System Gains FDA Clearance for Brain Tumor Biopsy and Neurosurgery
FDA & EMA | 2 May 2026
SUNRISE-II Trial Begins Evaluating Ultrasound-Guided HIFU Ablation for Pancreatic Cancer
Clinical Trials | 1 May 2026
FDA-Cleared Utepreva Device Aims to Improve Early Endometrial Cancer Detection
Cancer | 22 April 2026
FDA Approves Breakthrough Device: Altius System to Tackle Chronic Amputation Pain
Medical Devices | 31 August 2024
Monteris Introduces Smallest NB3 Laser Probe for Brain Tumor Surgery
Medical Devices | 1 May 2024
BioTrace: First FDA-Cleared Ultrasound Software for Liver Tumor Response Prediction
Medical Devices | 10 January 2024
World's First Chronic Migraine Therapy System Successfully Implanted in Six Patients
Medical Devices | 20 December 2023
Medtronic's PulseSelect PFA System Earns FDA Approval for Atrial Fibrillation Treatment
Medical Devices | 15 December 2023
BD Launches Vascular Access Ultrasound System to Enhance Clinician Efficiency
Medical Devices | 30 November 2023
How Soft Supercapacitors Could Transform the Future of Implantable Medical Devices?
Medical Devices | 26 November 2023
Subscribe for the latest news and events
Most Popular
Improving Everolimus Safety in Oncology: Missed Opportunities in Risk Minimization
Targeting the ‘Don’t Eat Me’ Signal: The Future of Macrophage Checkpoint Inhibitors
FDA Approves Wegovy to Reduce Risk of Heart Problems in Obese Adults
A New Era in Liver Disease: FDA Approves First Medication 'Rezdiffra' for NASH
Zongertinib Gains FDA Accelerated Approval for HER2+ NSCLC with 75% ORR
Exploring the Transformative Power of AI in Drug Discovery: A report by S&P Global
NETTER-2 Trial: Lutathera Cuts Risk of Death by 72% in Neuroendocrine Tumor Treatment
EpCAM-Targeting ADC CX-2051 Shows Promising Efficacy in Advanced Colorectal Cancer
FDA Grants Accelerated Approval to Semaglutide for MASH with Liver Fibrosis
Bayer Poised for Landmark Year with Blockbuster Treatment Advances Across Key Diseases
Transformative One-Time Gene Therapy: FDA Approves Pfizer's BEQVEZ, for Hemophilia B
NEJM Study Confirms Low-Dose Aspirin Halves Recurrence in Colorectal Cancer
FDA Approves Groundbreaking CAR T Cell Therapy, Abecma, for Multiple Myeloma
New Horizon in Food Allergy Treatment: FDA Approves Xolair for All Ages
FDA Approves Carvykti as Targeted CAR-T Cell Therapy for Multiple Myeloma